Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Pembrolizumab 400, Non-Small Cell Lung Cancer, Second Line

Protocol-ID: 1253 V1.0 (Mini), PEMB400, NSCLC, second line

Indication(s)

  • Lung Carcinoma, Non-Small Cell (PD-L1 from 1%); ICD-10 C34.-

Links

The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 22.05.2019